Sculptor Capital’s Zura Bio ZURA Stock Holding History

Sculptor Capital’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-183,090	Closed	-$1.87M	–	648
2022 Q4	$1.87M	Buy	183,090 +125,985	+221%	+$1.28M	0.03%	362
2022 Q3	$574K	Buy	57,105 +2,700	+5%	+$27K	0.01%	616
2022 Q2	$541K	Hold	54,405	–	–	0.01%	663
2022 Q1	$539K	Buy	+54,405	New	+$536K	﹤0.01%	742

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sculptor Capital's ZURA Position: Q1 2023 in Review

Sculptor Capital sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 183,090 shares — an estimated $1.87M sold.

Sculptor Capital first reported a position in ZURA in Q1 2022 and held it in 4 quarters. The position peaked at $1.87M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Sculptor Capital reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Sculptor Capital sold 183,090 Zura Bio shares in Q1 2023, an estimated $1.87M.
Sculptor Capital first reported a position in Zura Bio in Q1 2022 and held it in 4 quarters.
Sculptor Capital's Zura Bio position peaked at $1.87M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.